Surmodics | Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 50.83B 0 2025-09
Align Technology USD 3.96B 44.68M 2025-09
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 568.42M 102.37M 2025-12
Baxter International USD 7.24B 79M 2025-09
Boston Scientific USD 22.65B 235M 2025-09
EDAP TMS EUR 27.82M 13.07M 2025-06
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Haemonetics USD 911.45M 62.28M 2025-12
Heron Therapeutics USD 14.88M 42.14M 2025-09
J&J USD 78.47B 0 2025-09
Merit Medical Systems USD 1.53B 41.36M 2025-09
Mesa Laboratories USD 186.69M 8.22M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Option Care Health USD 1.36B 1.29M 2025-09
Stryker USD 21.78B 594M 2025-09
Surmodics USD 118.9M 753K 2024-09
Trinity Biotech USD -54.72M 5.18M 2025-09


Surmodics Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.